IRT Earnings Overview 20260526 SBFG Q1 2026 Earnings Strong Earnings Beat Fails to Lift Stock INAB Q1 2026 Earnings Narrowed Losses Exceed Expectations as Clinical Progress Continues DHCNL Q1 2026 Earnings EPS Misses Estimates Amid Continued Operational Headwinds ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher 22nd Century Group Q1 2026 Earnings Massive EPS Miss Sparks Investor Concern